Impact of Duration Of Absolute Voice Rest on Voice Outcome After Phonomicrosurgery
NCT ID: NCT02634957
Last Updated: 2020-04-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
17 participants
INTERVENTIONAL
2016-01-31
2020-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimal Duration of Voice Rest After Surgery for Benign Vocal Lesions
NCT04319432
Non-phonatory Exercises in Patients with Unilateral Vocal Fold Paralysis Post-thyroidectomy
NCT05963165
Functional Voice and Speech Outcomes Following Surgical Voice Restorations: A Comparison of Pharyngeal Construction Approaches
NCT00600223
Stapler Versus Conventional Pharyngeal Repair After Total Larygectomy
NCT06256263
A Personalized Voice Restoration Device for Patients With Laryngectomy
NCT05479643
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
3 day absolute voice rest
participants would begin initiation of voice/speaking 3 days post phonomicrosurgery for benign vocal fold lesions
absolute voice rest
absolute voice rest is the complete elimination of any vocalization (no sounds, speaking or whispering)
7 day absolute voice rest
participants would begin initiation of voice/speaking 7 days post phonomicrosurgery for benign vocal fold lesions
absolute voice rest
absolute voice rest is the complete elimination of any vocalization (no sounds, speaking or whispering)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
absolute voice rest
absolute voice rest is the complete elimination of any vocalization (no sounds, speaking or whispering)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Polyps
2. Cysts
3. Sub-epithelial fibrous mass
2. Undergoing elective phonomicrosurgery for vocal fold lesions, which involves microflap excision +/- truncation +/- steroid injection into the vocal folds.
3. Age 18 and older
9. Previous vocal fold surgery
10. Systemic steroids
11. History of systemic illness that could affect wound healing
Exclusion Criteria
1. Reinke's edema
2. Active smokers
3. Ligamentous mid membranous vocal fold lesions
4. RRP (Recurrent Respiratory Papillomatosis)
5. Dysplasia
6. CIS (Carcinoma-in-situ)
7. SCC (squamous cell carcinoma)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pittsburgh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Libby Smith DO
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Libby Smith, DO
Role: PRINCIPAL_INVESTIGATOR
University of Pittsburgh
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRO15120009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.